Two are from the School of Pharmacy
Science is a team sport, and a group of West Virginia University researchers with differing expertise and approaches are joining forces to seek a drug for non-small cell lung cancer (NSCLC).
The group, assembled by Lori Hazlehurst, Ph.D., associate director of basic research at the WVU Cancer Institute, has been awarded a one-year, $840,091 Team Science Supplement to an existing IDeA Networks of Biomedical Research Excellence (INBRE) grant. The supplement and the INBRE are funded by the National Institute of General Medical Sciences.